E-cadherin-expressing target cells are well known to inhibit the cytotoxicity of tumor-activated NK cells by binding to the receptor KLRG1 [107–109], but it is unclear whether virus-activated NK cells could be inhibited. The gene discussed is CDH1; the disease is neoplasm.